BML Investment Partners, L.P.

7 filings 4 distinct issuers Active 2022-07-07 → 2026-10-06

Track Record

Total filings

1 SCHEDULE 13G · 1 SCHEDULE 13G/A · 3 SCHEDULE · 2 SC

Distinct issuers

57% issuer diversity

Median stake

8.26%

2,435,000 avg shares

AI briefs cached

0/7

intent-classified filings

Backtested Performance · post-filing returns (split + dividend adjusted)

Median 30d

0.0%

across 3 filings · win rate 0%

Median 60d

0.0%

across 3 filings · win rate 0%

Median 90d

0.0%

across 3 filings · win rate 0%

Median 1y

0.0%

across 3 filings · win rate 0%

Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.

Filings · 7 total

Filed	Form	Issuer	Stake	Shares
2026-10-06	SCHEDULE 13G	Connect Biopharma Holdings LtdCNTB	—	—	view →
2026-06-29	SCHEDULE 13G/A	ORAMED PHARMACEUTICALS INC.ORMP	—	—	view →
2025-03-05	SCHEDULE	Aadi Bioscience, Inc.WHWK	4.98%	2,435,000	view →
2025-02-24	SCHEDULE	Aadi Bioscience, Inc.WHWK	9.90%	2,435,000	view →
2025-02-04	SCHEDULE	Aadi Bioscience, Inc.WHWK	9.90%	2,435,000	view →
2024-01-11	SC	Forte Biosciences, Inc.FBRX	—	—	view →
2022-07-07	SC	Forte Biosciences, Inc.FBRX	—	—	view →

Alert me when BML Investment Partners, L.P. files anything

Free. We email you when criteria match. One-click unsubscribe in every email.

Track this filer's every move in real time.

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →